🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The Women's Ischemia Study Evaluation (WISE), a cohort study of over 1000 w...
Status
Recruiting
Location
Cedars-Sinai Women's Heart Center
Start Date
2015-10
Trial ID
NCT02582021
This study included patients with glomerulonephritis who planned to receive...
Status
Unknown
Location
Changhai Hospital
Start Date
2023-02-01
Trial ID
NCT05761938
This is a Phase 1, open-label, first-in-human (FIH) dose-escalation study d...
Status
Completed
Location
Honor Health (GIST, mastocytosis, other solid tumors)
Start Date
2015-11
Trial ID
NCT02571036
This research study is designed to test the use of ranolazine in patients w...
Status
Completed
Location
127 S. San Vicente Blvd, Suite A9303
Start Date
2011-05
Trial ID
NCT01342029
Treatments Being Tested
Castleman disease, a rare lymphoproliferative disorder, is characterized by...
Status
Completed
Location
University of Pennsylvania
Start Date
2016-02
Trial ID
NCT02853968
Treatments Being Tested
The purpose of the Manual Cervical Distraction: Measuring Chiropractic Deli...
Status
Completed
Location
Palmer Center for Chiropractic Research
Start Date
2013-01
Trial ID
NCT01765751
Treatments Being Tested
This is a study with 2 parts. Part 1 comprises a visit to collect biologica...
Status
Terminated
Location
Aventiv Research - Phoenix
Start Date
2019-12-20
Trial ID
NCT04235621
Treatments Being Tested
To evaluate the safety and efficacy of ripertamab and its combination with ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-05
Trial ID
NCT06405100
Treatments Being Tested
This is a Phase 1b/2, open-label, multi-center study evaluating the therape...
Status
Recruiting
Location
Peking University First Hospital
Start Date
2026-05-20
Trial ID
NCT07614477
Treatments Being Tested
In this study, safety and effects of MUC1-gene-DC-CTL and MUC1-peptide-DC-C...
Status
Unknown
Location
First Affiliated Hospital of Henan University of Science and Technology
Start Date
2017-10
Trial ID
NCT02602249
Treatments Being Tested